- Researchers say an HIV vaccine that's on trial in South Africa could finally defeat the virus
- South Africa is host to around 14 HIV prevention studies
- Over 4,600 people have enrolled for the trials
HIV researchers are optimistic that a vaccine that's on trial in South Africa could finally defeat what has been dubbed "the world's cleverest virus."
This was the prevailing view at the HIV Research for Prevention (HIVR4P) conference held in Madrid‚ Spain, last week.
Researchers announced at the conference that over 4,600 people in Africa, US, and South America have enrolled for the trials, TimesLIVE reports.
South Africa is host to around 14 HIV prevention studies, the most in the world. It also has the world's largest antiretroviral programme, Briefly.co.za gathered.
Around 1‚900 HIV-negative women between the ages of 18 and 24 are participating in the female study. They are spread across Gauteng‚ KwaZulu-Natal‚ Western Cape‚ and several African countries.
Larry Corey, HIVR4P's prevention trials network principal investigator, said the trials will go a long way in improving previous studies:
By now we have established that it’s incredibly safe to use [the vaccine's antibodies] on humans‚ but we want to know what works best‚ which dose of antibodies is the right amount.
Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!